Genenta Science S.p.A. (GNTA)
GNTA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.7220
-4.99% on the day
Market cap
$34.8M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | GNTA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Italy |
| IPO year | 2021 |
| SEC CIK | 0001838716 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | L6 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-01-27 |
| Latest annual report | 20-F | 2026-04-01 |
| Latest quarterly / interim | 6-K | 2026-10-13 |
Source: SEC EDGAR submissions feed, 116 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MGX | Metagenomi Therapeutics Inc. | $0.9173 | -10.07% | $34.7M |
| ALGS | Aligos Therapeutics Inc. | $5.51 | -0.36% | $34.4M |
| ELUT | Elutia Inc. | $0.7732 | -1.75% | $34.2M |
| CVM | Cel-Sci Corporation | $1.75 | -4.37% | $30.8M |
| TIL | Instil Bio Inc. | $6.18 | -6.08% | $41.9M |
| BSEM | BioStem Technologies Inc. | $2.25 | -7.79% | $42.0M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier